tafluprost
Sign in to saveAlso known as AFP-168, MK-2452, Taflotan®, Tafluprosttrade
Tafluprost (trade names Taflotan by Santen Pharmaceutical, Zioptan by Merck in the US and Saflutan by Mundipharma in Australia) is a prostaglandin analogue. It is used topically (as eye drops) to control the progression of open-angle glaucoma and in the management of ocular hypertension, alone or in combination with other medication. It reduces intraocular pressure by increasing the outflow of aqueous fluid from the eyes.
~4 min read
Encyclopedic overview
6 sectionsContents
- Adverse effects
- Interactions
- Pharmacology
- Mechanism of action
- Pharmacokinetics
- References
{{Drugbox | IUPAC_name = Isopropyl (5Z)-7-{(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoate | image = Tafluprost_structure.svg | image_class = skin-invert-image
| tradename = Saflutan, Taflotan, Zioptan | Drugs.com = | pregnancy_AU = | pregnancy_category = | legal_AU = | legal_CA = Rx-only | legal_CA_comment = | legal_UK = | legal_US = Rx-only | legal_status = | routes_of_administration = Topical eye drops
Excerpted from Wikipedia’s “tafluprost” article, available under the CC BY-SA 4.0 licence.
Gallery (2)
Available in 15 languages
- Español
- Français
- 中文
- 日本語
- Русский
- العربية
- Bahasa Indonesia
- Nederlands
- Odia
- Serbian
- Serbian (Latin)
- Telugu
- فارسی
- 한국어
via Wikidata sitelinks · CC0